We are the leading Spanish company marketing R&D products nationally and internationally.

R&D centres

Almirall has over 550 highly qualified professionals dedicated to R&D in three distinct sites.

Almirall Sant Feliu R&D centre

Almirall's Sant Feliu R&D centre in the outskirts of Barcelona was inaugurated in 2006 and represents the largest investment made by the pharmaceutical industry in Spain. This facility with a surface area of more than 27,500m2 and equipped with the most advanced technological resources, represents a benchmark for biomedical research in Spain.

In Sant Feliu, our scientists enjoy a state-of-the-art R&D centre that has brought together all the different skill sets necessary to discover and develop medicines that address unmet medical needs within our therapeutic area.

Laureà Miró, 408-410
08980 Sant Feliu de Llobregat
Barcelona - Spain
Tel. + 34 93 291 30 00
Fax + 34 93 291 29 97


Almirall Sofotec R&D Centre

This is a centre of excellence in pharmaceutical development, located in the German town of Bad-Homburg, near Frankfurt, dedicated to designing and developing devices for inhaled drug delivery.

Benzstrasse 1-3
61352 Bad Homburg
Germany
Tel. + 49 (0)6172 6809 0
Fax + 49 (0)6172 6809 1111

www.almirallsofotec.com


Almirall Reinbek/Dermatology R&D Centre

As a result of Almirall's acquisition of Hermal, a Dermatology Centre of Excellence has been established in Reinbek, just outside Hamburg (Germany). This R&D site performs research into the treatment of skin alterations for topical delivery.

Scholtzstrasse 3
21465 Reinbek
Germany

Tel. + 49 (0)40 727 04 0
Fax + 49 (0)40 722 92 96

www.almirall.de, www.hermal.com


In addition Almirall's Sant Andreu de la Barca chemical plant also houses our Active Ingredient scale-up unit collaborating with R&D in the production of material destined for corresponding toxicology studies and clinical trials.

Ctra. Nacional II, km. 593
08740 Sant Andreu de la Barca
Barcelona - Spain
Tel. + 34 93 291 30 00
Fax + 34 93 291 33 44

Genuair

Therapeutic efficacy favoured by a safe and easy to use administration

Genuair is a registered trademark of Almirall, S.A.. It is the proposed trademark for the MDPI and is pending regulatory approval.

Dermatology

Focused on the development of new topical treatments